Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O; Haugaard, S B; Holst, Jens Juul; Deacon, C F; Iversen, J; Andersen, U B; Nielsen, J O; Madsbad, S.

    In: HIV Medicine, Vol. 6, No. 2, 03.2005, p. 91-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Enhanced glucagon-like peptide- 1 (GLP-1) response to oral glucose in glucose intolerant HIV-infected patients on antiretroviral therapy. / Andersen, O.; Haugaard, S.B.; Holst, Jens Juul; Deacon, Carolyn F.; Iversen, J.; Andersen, U.B.; Nielsen, J.O.; Madsbad, S.

    In: HIV Medicine, Vol. 6, 2005, p. 91-98.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Glucagon-like peptide-2 (GLP-2) response to enteral intake in children during anti-cancer treatment. / Andreassen, B U; Paerregaard, A; Schmiegelow, K; Rechnitzer, C; Heilman, C; Hartmann, B; Holst, Jens Juul; Michaelsen, K F.

    In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 40, No. 1, 01.2005, p. 48-53.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like-peptide-2 (GLP-2) response to enteral intake in children during anticancer treatment. / Andreassen, B.U.; Pærregaard, A.; Schmiegelow, K.; Rechnitzer, C.; Hartmann, Bolette; Holst, Jens Juul; Michaelsen, K.F.

    In: Journal of Pediatric Gastroenterology and Nutrition, No. 40, 2005, p. 48-53.

    Research output: Contribution to journalJournal articleResearch

  5. Published

    Lower-body fat mass as an independent marker of insulin sensitivity - the role of adiponectin? / Buemann, B.; Black, E.; Sørensen, T.I.A.; Holst, C.; Toubro, S.; Pedersen, O.; Holst, J.J.; Rasmussen, C.; Astrup, Arne.

    In: International Journal of Obesity, No. 29, 2005, p. 624-631.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    GLP-2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, D.G.; Stoll, B.; Guan, X.; Cui, L.; Chang, X.; Holst, Jens Juul.

    In: Endokrinologiya, No. 146, 2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearch

  7. Published

    Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. / Burrin, Douglas G; Stoll, Barbara; Guan, Xinfu; Cui, Liwei; Chang, Xiaoyan; Holst, Jens Juul.

    In: Endocrinology, Vol. 146, No. 1, 01.2005, p. 22-32.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction. / Carstensen, Marius; Thomsen, Claus; Gotzsche, Ole; Holst, Jens Juul; Schrezenmeir, Jürgen; Hermansen, Kjeld.

    In: The review of diabetic studies : RDS, Vol. 1, No. 4, 2005, p. 175-84.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes. / Deacon, Carolyn F; Holst, Jens J.

    In: International Journal of Biochemistry & Cell Biology, Vol. 38, No. 5-6, 2005, p. 831-44.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Exenatide augments first and second phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, F.; Trautmann, M.; Holst, J.J.; Halseth, A.E.; Nanyakkara, N.; Nielsen, L.; Fineman, M.S.D.; Kim, D.D.; Nauck, M.A.

    In: J. Clin. Endocrinol. Metab., No. 90, 2005, p. 5991-5997.

    Research output: Contribution to journalJournal articleResearch

  11. Published

    Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. / Fehse, Frauke; Trautmann, Michael; Holst, Jens Juul; Halseth, Amy E; Nanayakkara, Nuwan; Nielsen, Loretta L; Fineman, Mark S; Kim, Dennis D; Nauck, Michael A.

    In: The Journal of clinical endocrinology and metabolism, Vol. 90, No. 11, 11.2005, p. 5991-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    The use of glycaemic index tables to predict glycaemic index of breakfast meals. / Flint, Anne; Møller, Bente Kramer; Raben, Anne; Tetens, Inge; Holst, Jens Juul; Astrup, Arne.

    In: British Journal of Nutrition, Vol. 94, No. 1, 2005, p. 135-136.

    Research output: Contribution to journalLetterResearchpeer-review

  13. Published

    Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. / Frid, Anders H; Nilsson, Mikael; Holst, Jens Juul; Björck, Inger M E.

    In: American Journal of Clinical Nutrition, Vol. 82, No. 1, 2005, p. 69-75.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. / Haugaard, Steen B; Andersen, Ove; Dela, Flemming; Holst, Jens Juul; Storgaard, Heidi; Fenger, Mogens; Iversen, Johan; Madsbad, Sten.

    In: European Journal of Endocrinology. Supplement, Vol. 152, No. 1, 01.2005, p. 103-12.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. / Haugaard, Steen B; Andersen, Ove; Dela, Flemming; Holst, Jens Juul; Storgaard, Heidi; Fenger, Mogens; Iversen, Johan; Madsbad, Sten; Haugaard, Steen B; Andersen, Ove; Dela, Flemming; Holst, Jens Juul; Storgaard, Heidi; Fenger, Mogens; Iversen, Johan; Madsbad, Sten.

    In: European Journal of Endocrinology, Vol. 152, No. 1, 2005, p. 103-112.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    GLP-1 receptor argonists for the treatment of diabetes. / Holst, J.J.

    In: International Diabetes Monitor, No. 17, 2005, p. 11-18.

    Research output: Contribution to journalJournal articleResearch

  17. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. / Holst, Jens Juul; Deacon, C F.

    In: Diabetologia, Vol. 48, No. 4, 04.2005, p. 612-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Glucagon-like peptide 1: physiology and therapeutic potential. / Holst, Jens Juul.

    In: Endocrinology and Diabetes, No. 12, 2005, p. 56-62.

    Research output: Contribution to journalJournal articleResearch

  19. Published

    On the physiology of GIP and GLP-1. / Holst, Jens Juul.

    In: Hormone and Metabolic Research. Supplement, Vol. 36, No. 11-12, 19.01.2005, p. 747-54.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1? / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. / Hücking, K; Kostic, Z; Pox, C; Ritzel, R; Holst, Jens Juul; Schmiegel, W; Nauck, M A.

    In: Diabetic Medicine, Vol. 22, No. 4, 04.2005, p. 470-6.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Alpha-Glucosidase inhibition (Acarbose) fails to enhance secretion of glucagons-like peptide 1(7-36 amide) and to delay gastric emptying in type 2 diabetic patients. / Hücking, K.; Kostic, Z.; Pox, C.; Ritzel, R.; Holst, Jens Juul; Schmiegel, W.; Nauck, M.A.

    In: Diabet. Med., No. 22, 2005, p. 470-476.

    Research output: Contribution to journalJournal articleResearch

  24. Published

    Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls. / Jensen, Christine B; Storgaard, Heidi; Holst, Jens Juul; Dela, Flemming; Madsbad, Sten; Vaag, Allan.

    In: Metabolism - Clinical and Experimental, Vol. 54, No. 10, 2005, p. 1398-406.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Teduglutide (ALX-0600), a dipeptidyl-peptidase-IV resistant glucagon-like-2 analog improves intestinal function in short bowel syndrome patients. / Jeppesen, P.B.; Sanguinetti, E.L.; Buckman, A.; Howard, L.; Scolapio, J.S.; Ziegler, T.R.; Gregory, M.; Tappendent, K.A.; Holst, Jens Juul; Mortensen, P.B.

    In: Gut, No. 54, 2005, p. 1224-1231.

    Research output: Contribution to journalJournal articleResearch

Previous 1 2 3 Next

ID: 4207